Intact Olfaction in a Mouse Model of Multiple System Atrophy

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Krismer, Florian ^a   Wenning, Gregor K ^a   Li, Yuntao ^a,b   Poewe, Werner ^a   Stefanova, Nadia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; TYROSINE 3 MONOOXYGENASE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOUSE; NEUROPATHOLOGY; NONHUMAN; OLFACTORY BULB; OLIGODENDROGLIA; PILOT STUDY; SHY DRAGER SYNDROME; SMELLING; TRANSGENIC MOUSE; AGE; ANALYSIS OF VARIANCE; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GENOTYPE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; ODOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

AGE FACTORS; ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; ANIMALS; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GENOTYPE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MULTIPLE SYSTEM ATROPHY; OLFACTORY BULB; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; SMELL;

EID: 84877861755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064625     Document Type: Article

References (34)

1. Wenning GK, Colosimo C, Geser F, Poewe W, (2004) Multiple system atrophy. Lancet Neurol 3: 93-103.
2. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ, (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125: 861-870.
3. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, et al. (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91: 247-250.
4. Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, et al. (2011) The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy. BMC Neurol 11: 157.
5. Glass PG, Lees AJ, Mathias C, Mason L, Best C, et al. (2012) Olfaction in pathologically proven patients with multiple system atrophy. Mov Disord 27: 327-328.
6. Kikuchi A, Baba T, Hasegawa T, Sugeno N, Konno M, et al. (2011) Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism Relat Disord 17: 698-700.
7. Garland EM, Raj SR, Peltier AC, Robertson D, Biaggioni I, (2011) A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology 76: 456-460.
8. Doty RL, (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8: 329-339.
9. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, et al. (2008) Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 63: 167-173.
10. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI, (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55: 138-142.
11. Doty RL, Deems DA, Stellar S, (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38: 1237-1244.
12. Kovacs T, Papp MI, Cairns NJ, Khan MN, Lantos PL, (2003) Olfactory bulb in multiple system atrophy. Mov Disord 18: 938-942.
13. Pearce RK, Hawkes CH, Daniel SE, (1995) The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10: 283-287.
14. Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, et al. (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3: 583-588.
15. Shults CW, Rockenstein E, Crews L, Adame A, Mante M, et al. (2005) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 25: 10689-10699.
16. Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, et al. (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45: 847-859.
17. Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, et al. (2002) Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68: 568-578.
18. Kim YH, Lussier S, Rane A, Choi SW, Andersen JK, (2011) Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 172: 379-386.
19. Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, et al. (2008) Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 28: 247-256.
20. Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, et al. (2009) Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 29: 8103-8113.
21. Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Mohedano-Moriano A, Fradejas N, et al. (2010) Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved. Mov Disord 25: 1701-1707.
22. Nuber S, Petrasch-Parwez E, Arias-Carrion O, Koch L, Kohl Z, et al. (2011) Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiol Dis 44: 192-204.
23. Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O'Connell M, et al. (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci 26: 3942-3950.
24. Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, et al. (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30: 6236-6246.
25. Witt RM, Galligan MM, Despinoy JR, Segal R, (2009) Olfactory behavioral testing in the adult mouse. J Vis Exp 23: 949.
26. Kobayakawa K, Kobayakawa R, Matsumoto H, Oka Y, Imai T, et al. (2007) Innate versus learned odour processing in the mouse olfactory bulb. Nature 450: 503-508.
27. Stefanova N, Kaufmann WA, Humpel C, Poewe W, Wenning GK, (2012) Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol 124: 51-65.
28. Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK, (2012) Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res 21: 393-404.
29. Stefanova N, Hainzer M, Stemberger S, Couillard-Despres S, Aigner L, et al. (2009) Striatal transplantation for multiple system atrophy-are grafts affected by alpha-synucleinopathy? Exp Neurol 219: 368-371.
30. Stemberger S, Poewe W, Wenning GK, Stefanova N, (2010) Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 224: 459-464.
31. Nee LE, Scott J, Polinsky RJ, (1993) Olfactory dysfunction in the Shy-Drager syndrome. Clin Auton Res 3: 281-282.
32. Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T, (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9: 521-524.
33. Goldstein DS, Sewell L, (2009) Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord 15: 516-520.
34. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, et al. (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord 22: 2196-2203.